0.43NGN
510.80 MNGN
16.44 BNGN
640.99 M
About GALAXO SMITHKLINE CONSUMER PLC - NIGERIA
GlaxoSmithKline Consumer Nigeria Plc engages in the manufacture, marketing, and distribution of consumer healthcare and pharmaceutical products. It operates through the Consumer Healthcare and Pharmaceuticals segments. The Consumer Healthcare segment includes nutritional healthcare, oral care, and over-the-counter medicines. The Pharmaceutical segment offers antibacterial, vaccines, and prescription drugs. The company was founded on June 23, 1971 and is headquartered in Lagos, Nigeria.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GLAXOSMITH is 17.00 NGN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSENG exchange GALAXO SMITHKLINE CONSUMER PLC - NIGERIA stocks are traded under the ticker GLAXOSMITH.
GLAXOSMITH stock is 0% volatile and has beta coefficient of 0.05. Check out the list of the most volatile stocks — is GALAXO SMITHKLINE CONSUMER PLC - NIGERIA there?
Yes, you can track GALAXO SMITHKLINE CONSUMER PLC - NIGERIA financials in yearly and quarterly reports right on TradingView.
GLAXOSMITH net income for the last quarter is 62.72 M NGN, while the quarter before that showed 108.36 M NGN of net income which accounts for −42.12% change. Track more GALAXO SMITHKLINE CONSUMER PLC - NIGERIA financial stats to get the full picture.
Like other stocks, GLAXOSMITH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GALAXO SMITHKLINE CONSUMER PLC - NIGERIA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GALAXO SMITHKLINE CONSUMER PLC - NIGERIA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GALAXO SMITHKLINE CONSUMER PLC - NIGERIA stock shows the buy signal. See more of GALAXO SMITHKLINE CONSUMER PLC - NIGERIA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GALAXO SMITHKLINE CONSUMER PLC - NIGERIA EBITDA is −141.11 M NGN, and current EBITDA margin is −1.21%. See more stats in GALAXO SMITHKLINE CONSUMER PLC - NIGERIA financial statements.